未登录

Y

Young Up Cho

Inha University

H指数:23

被引数:1,362

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

On-treatment derived neutrophil-to-lymphocyte ratio and survival with palbociclib and endocrine treatment: analysis of a multicenter retrospective cohort and the PALOMA-2/3 study with immune correlates

BREAST CANCER RESEARCH

IF5.6

2023-01-1211

OAAI

Effects of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors: A randomized controlled trial

基于伙伴关系的，量身定制的自我管理支持干预对治疗后乳腺癌幸存者的影响: 一项随机对照试验

PSYCHO-ONCOLOGY

IF3.5

2021-09-2711

PREAI

Genomic landscape of extraordinary responses in metastatic breast cancer

COMMUNICATIONS BIOLOGY

IF5.1

2021-04-095

OAAI

Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer (vol 83, pg 421, 2020)

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-07-140

OAAI

Optimal treatment of pseudoangiomatous stromal hyperplasia of the breast

ASIAN JOURNAL OF SURGERY

IF3.8

2020-07-0117

OAAI

Palbociclib use with grade 3 neutropenia in hormone receptor-positive metastatic breast cancer

BREAST CANCER RESEARCH AND TREATMENT

IF3

2020-06-234

PREAI

Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors

针对治疗后乳腺癌幸存者的基于伙伴关系，量身定制的自我管理支持干预的随机对照试验的设计

IF3.4

2020-05-016

OAAI

Robot-assisted Nipple-sparing Mastectomy with Immediate Breast Reconstruction: An Initial Experience (vol 9, 15669, 2019)

SCIENTIFIC REPORTS

IF3.9

2020-04-300

OAAI

First Experience in Korea of Stereotactic Partial Breast Irradiation for Low-Risk Early-Stage Breast Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-04-2911

OAAI

Intermediate HER2 expression predicts poor prognosis in ER (+) breast cancer patients aged 55 and older

CANCER RESEARCH

IF16.6

2020-02-150

PRE

Comprehensive analysis of lymphopenia in large-scaled early and metastatic breast cancer database cohort

CANCER RESEARCH

IF16.6

2020-02-150

PRE

Intermediate HER2 expression is associated with poor prognosis in estrogen receptor-positive breast cancer patients aged 55 years and older

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-12-0614

PREAI

Robot-assisted Nipple-sparing Mastectomy with Immediate Breast Reconstruction: An Initial Experience

SCIENTIFIC REPORTS

IF3.9

2019-10-3041

OAAI

Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30

BREAST CANCER RESEARCH

IF5.6

2019-10-1610

OAAI

Risk of Lymphedema Following Contemporary Treatment for Breast Cancer An Analysis of 7617 Consecutive Patients From a Multidisciplinary Perspective

ANNALS OF SURGERY

IF6.4

2019-07-2380

PREAI

Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort

BREAST CANCER RESEARCH AND TREATMENT

IF3

2019-02-0415

PREAI

Prevalence of breast cancer-related risk factors in underweight premenopausal women: the Korea National Health and Nutrition Examination Survey IV-VI

BREAST CANCER RESEARCH AND TREATMENT

IF3

2018-12-174

PREAI

BRCA1/2-negative, high-risk breast cancers (BRCAX) for Asian women: genetic susceptibility loci and their potential impacts

SCIENTIFIC REPORTS

IF3.9

2018-10-1522

OAAI

The impact of rapid changes in reproductive factors on the increased incidence of breast cancer in Korea

CANCER RESEARCH

IF16.6

2018-07-010

PRE

PD-1 and TIGIT are major immune checkpoint receptors expressed in breast cancer-infiltrating T cells

CANCER RESEARCH

IF16.6

2017-07-011

PRE